
Incidence of Metastatic Well-Differentiated Thyroid Cancer in Cervical Lymph Nodes
Tracy S. Wang, MD;
Sanford Dubner, MD;
Laura A. Sznyter, MD;
Keith S. Heller, MD
Arch Otolaryngol Head Neck Surg. 2004;130:110-113.
Objective To determine the incidence of clinically positive lateral cervical nodes at presentation and after initial treatment in patients with well-differentiated thyroid cancer.
Design Retrospective chart review.
Setting University-affiliated teaching hospitals.
Patients A total of 508 patients who underwent a thyroidectomy as part of their initial treatment for well-differentiated thyroid carcinoma between January 1978 and December 1999. Neck dissections were performed only for clinically palpable cervical nodes.
Main Outcome Measures Recurrence in the neck and survival.
Results Forty-four patients (9%) had palpable lateral cervical lymph nodes at the time of surgery. All 31 patients younger than 45 years presenting with palpable positive nodes are alive and free of disease; 4 of 13 patients 45 years or older have died of thyroid cancer. Only 16 (3%) of 464 patients who did not undergo initial neck dissection had recurrence in lateral cervical nodes. Recurrence is more likely when the initial tumor is larger than 4 cm. In 216 patients younger than 45 years, there were 5 (2%) recurrences in lateral cervical nodes; these patients remain alive and free of disease. In 248 patients 45 years or older, there were 11 (4%) with recurrent disease in the lateral neck; 4 of these patients have died of thyroid cancer.
Conclusions An aggressive approach to detecting and treating occult lateral cervical nodes by techniques such as jugular node sampling, sentinel node biopsy, or image-guided needle biopsy is not necessary in most patients. Attempts to detect and remove occult lateral cervical lymph node metastases might be considered in older patients with large primary tumors.
From the Section of Head and Neck Surgery, Department of Surgery, Long Island Jewish Medical Center, The Long Island Campus of the Albert Einstein College of Medicine, New Hyde Park, NY. The authors have no relevant financial interest in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less Than 2 cm: Implications for Radioiodine Treatment
Bonnet et al.
J. Clin. Endocrinol. Metab. 2009;94:1162-1167.
ABSTRACT
| FULL TEXT
Utility of Computed Tomography in the Detection of Subclinical Nodal Disease in Papillary Thyroid Carcinoma
Soler et al.
Arch Otolaryngol Head Neck Surg 2008;134:973-978.
ABSTRACT
| FULL TEXT
Impact of Preoperative Ultrasonographic Staging of the Neck in Papillary Thyroid Carcinoma
Gonzalez et al.
Arch Otolaryngol Head Neck Surg 2007;133:1258-1262.
ABSTRACT
| FULL TEXT
The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer.
Shindo et al.
Arch Otolaryngol Head Neck Surg 2006;132:650-654.
ABSTRACT
| FULL TEXT
High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph Nodes
Vasko et al.
J. Clin. Endocrinol. Metab. 2005;90:5265-5269.
ABSTRACT
| FULL TEXT
|